Phosphoglycerate kinase 1 (PGK1), a key enzyme in aerobic glycolysis, is inhibited by miR-16–1-3p in BC patients, repressing cell proliferation, migration, invasion, and metastasis by inhibiting the PGK1-mediated Warburg effect [110]. Here, PGK1 is linked to breast cancer.